Deferred Income Tax Liabilities, Net in USD of BIO-TECHNE Corp from Q2 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
BIO-TECHNE Corp quarterly Deferred Income Tax Liabilities, Net history and change rate from Q2 2019 to Q3 2025.
  • BIO-TECHNE Corp Deferred Income Tax Liabilities, Net for the quarter ending 30 Sep 2025 was $11.3M, a 77.5% decline year-over-year.
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Change (%)

BIO-TECHNE Corp Quarterly Deferred Income Tax Liabilities, Net (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $11.3M -$38.7M -77.5% 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 $6.17M -$49.7M -89% 30 Jun 2025 10-Q 05 Nov 2025
Q1 2025 $31.9M -$31.7M -49.9% 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $37.7M -$33.9M -47.3% 31 Dec 2024 10-Q 06 Feb 2025
Q3 2024 $50M -$33.1M -39.8% 30 Sep 2024 10-Q 05 Nov 2024
Q2 2024 $55.9M -$33.1M -37.2% 30 Jun 2024 10-K 22 Aug 2025
Q1 2024 $63.7M -$30.9M -32.7% 31 Mar 2024 10-Q 06 May 2024
Q4 2023 $71.6M -$39.8M -35.7% 31 Dec 2023 10-Q 07 Feb 2024
Q3 2023 $83.1M -$29.8M -26.4% 30 Sep 2023 10-Q 07 Nov 2023
Q2 2023 $89M -$10M -10.1% 30 Jun 2023 10-K 22 Aug 2024
Q1 2023 $94.6M -$4.69M -4.73% 31 Mar 2023 10-Q 08 May 2023
Q4 2022 $111M +$9.96M +9.82% 31 Dec 2022 10-Q 07 Feb 2023
Q3 2022 $113M +$14.1M +14.3% 30 Sep 2022 10-Q 07 Nov 2022
Q2 2022 $99M +$5.87M +6.3% 30 Jun 2022 10-K 23 Aug 2023
Q1 2022 $99.3M +$900K +0.92% 31 Mar 2022 10-Q 09 May 2022
Q4 2021 $101M -$3.92M -3.72% 31 Dec 2021 10-Q 07 Feb 2022
Q3 2021 $98.8M -$2.56M -2.53% 30 Sep 2021 10-Q 08 Nov 2021
Q2 2021 $93.1M -$7.97M -7.88% 30 Jun 2021 10-K 24 Aug 2022
Q1 2021 $98.4M +$2.22M +2.31% 31 Mar 2021 10-Q 07 May 2021
Q4 2020 $105M 31 Dec 2020 10-Q 08 Feb 2021
Q3 2020 $101M 30 Sep 2020 10-Q 09 Nov 2020
Q2 2020 $101M +$11.3M +12.6% 30 Jun 2020 10-K 25 Aug 2021
Q1 2020 $96.2M 31 Mar 2020 10-Q 11 May 2020
Q2 2019 $89.8M 30 Jun 2019 10-K 26 Aug 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.